tiprankstipranks
Akari Therapeutics (AKTX)
NASDAQ:AKTX
US Market
AKTX
Akari Therapeutics
RESEARCH TOOLSreports

Akari Therapeutics (AKTX) Financial Statements

350 Followers

Akari Therapeutics Financial Overview

Akari Therapeutics's market cap is currently $4.39M. The company's EPS TTM is $-1.495; its P/E ratio is -0.56; Akari Therapeutics is scheduled to report earnings on April 7, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -17.27M$ -21.64M$ -16.81M$ -23.09M$ -17.21M
EBITDA$ -17.27M$ -19.53M$ -16.80M$ -23.08M$ -17.21M
Net Income$ -17.30M$ -19.79M$ -10.01M$ -17.75M$ -17.42M
Balance Sheet
Cash & Short-Term Investments$ 5.20M$ 2.60M$ 3.85M$ 13.25M$ 9.36M
Total Assets$ 47.89M$ 50.56M$ 4.36M$ 13.83M$ 11.65M
Total Debt$ 754.00K$ 3.26M$ 0.00$ 0.00$ 0.00
Net Debt$ -4.45M$ 661.00K$ -3.85M$ -13.25M$ -9.36M
Total Liabilities$ 19.56M$ 28.33M$ 4.58M$ 12.04M$ 6.09M
Stockholders' Equity$ 28.33M$ 22.23M$ -229.00K$ 1.79M$ 5.55M
Cash Flow
Free Cash Flow$ -10.57M$ -12.55M$ -16.43M$ -21.50M$ -18.85M
Operating Cash Flow$ -10.57M$ -12.55M$ -16.43M$ -21.50M$ -18.85M
Investing Cash Flow$ 0.00$ 382.00K$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 13.17M$ 10.99M$ 7.02M$ 25.29M$ 14.29M
Currency in USD

Akari Therapeutics Earnings and Revenue History

Income Statement >

Akari Therapeutics Debt to Assets

Balance Sheet >

Akari Therapeutics Cash Flow

Cash Flow >

Akari Therapeutics Forecast EPS vs Actual EPS

Earnings >